Drug Research
Novel Method To Stop Antibody From Blocking Transplant Cells
Researchers at UCSF have developed a novel, potentially life-saving technique that may prevent antibodies from prompting the immune system to reject specifically tailored therapeutic and transplant cells.
It has been particularly difficult to cure rejection caused by antibodies as opposed...
Drug Research
US FDA approves Polarean Imaging’s drug device combination product, Xenoview
Polarean Imaging plc, the medical imaging technology company, announces that the US Food and Drug Administration (FDA) has granted approval for its drug device combination product, Xenoview.
Xenoview, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast...
Drug Research
PeptiDream, Merck Enter Peptide Drug Conjugates Pact
PeptiDream Inc., a Japan-based biopharmaceutical company, has entered a new multi-target collaboration and license agreement with Merck & Co, Inc. (known as MSD outside the U.S.) focused on the discovery and development of novel peptide drug conjugates (PDCs).
PeptiDream will...
Drug Research
Everest Medicines Begins Ops at mRNA Vaccine Production Site in China
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, began the first phase of operations at its global manufacturing site dedicated to mRNA vaccine production in Jiashan, Zhejiang Province.
The first phase...
Drug Research
Global Alliance Uncovers Genetic Basis For Brain Condition
The recognition of a previously unidentified genetic cause of late-onset cerebellar ataxia is reported in a new study that was released recently in the New England Journal of Medicine. This finding will help with the diagnosis and open up...
Drug Research
Finding Drugs That Fight Bacteria With Multi-Drug Resistance
Antibiotic usage is crucial in the treatment of many bacterial infections. However, the quantity of bacteria strains that are impervious to numerous antibiotics is increasing as a result of ongoing overuse and misuse, which is hurting millions of people...
Drug Research
WHO Authorizes PAXLOVID, The First Oral COVID-19 Generic
The generic version of the COVID-19 oral antiviral therapy candidate nirmatrelvir has been approved by the World Health Organization Prequalification of Medicines Program (WHO PQ), as stated by the Indian pharmaceutical company Hetero.
This is the first prequalification for a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read